Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Protagonist Therapeutics Inc.
DescriptionIntegrin alpha(4)beta(7) peptide antagonist
Molecular Target Integrin alpha(4)beta(7)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel diseases (IBD); Treat moderate-to-severe ulcerative colitis (UC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today